Safety of crizotinib in 892 Japanese ALK-positive advanced NSCLC patients: Interim report of post-marketing surveillance

被引:0
作者
Okamoto, Isamu [1 ]
Nakagawa, Kazuhiko [2 ]
Ohe, Yuichiro [3 ]
Ueno, Naomi [4 ]
Banno, Shigeo [4 ]
Endo, Yutaka [4 ]
Ohki, Emiko [4 ]
Gemma, Akihiko [5 ]
机构
[1] Kyusyu Univ Hosp, Ctr Clin & Transrat Res, Fukuoka, Japan
[2] Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan
[3] Natl Canc Ctr, Dept Resp Med, Tokyo, Japan
[4] Pfizer Japan Inc, Tokyo, Japan
[5] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo 113, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SY12-3
引用
收藏
页码:37 / 37
页数:1
相关论文
共 50 条
[31]   INTERIM REPORT OF A POST-MARKETING SURVEILLANCE OF PALIPERIDONE PALMITATE 3-MONTH FORMULATION IN JAPANESE PATIENTS WITH SCHIZOPHRENIA [J].
Marumoto, Tatsuro ;
Saga, Yosuke ;
Kinoshita, Hiroaki ;
Morita, Natsuko ;
Touma, Tokiko ;
Wakamatsu, Shinya ;
Takebe, Kyoko ;
Wakamatsu, Akihide ;
Chiang, Chih-Lin .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 :i160-i160
[33]   Brigatinib in pretreated patients with ALK-positive advanced NSCLC. [J].
Descourt, Renaud ;
Perol, Maurice ;
Rousseau-Bussac, Gaelle ;
Planchard, David ;
Mennecier, Bertrand ;
Wislez, Marie ;
Cortot, Alexis B. ;
Guisier, Florian ;
Gervais, Radj ;
Galland, Loick ;
Schott, Roland ;
Dansin, Eric ;
Arrondeau, Jennifer ;
Auliac, Jean-Bernard ;
Chouaid, Christos .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[34]   Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan [J].
Haruyuki Hongo ;
Takako Nagao ;
Kyoko Nakamura ;
Tomomi Kitaichi ;
Yuko Maeno ;
Teruhisa Tokunaga ;
Akiko Fukuda ;
Ichiro Koga .
Advances in Therapy, 2021, 38 :4480-4504
[35]   Long-Term Efficacy and Safety of Lorlatinib in Japanese Patients With ALK-Positive Advanced NSCLC-A Brief Report From the CROWN Study [J].
Teraoka, Shunsuke ;
Hayashi, Hidetoshi ;
Goto, Yasushi ;
Nishio, Makoto ;
Sugawara, Shunichi ;
Inoue, Takako ;
Oizumi, Satoshi ;
Toyoizumi, Shigeyuki ;
Matsumura, Masakazu ;
Messina, Rossella ;
Kato, Terufumi .
JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (03)
[36]   Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan [J].
Hongo, Haruyuki ;
Nagao, Takako ;
Nakamura, Kyoko ;
Kitaichi, Tomomi ;
Maeno, Yuko ;
Tokunaga, Teruhisa ;
Fukuda, Akiko ;
Koga, Ichiro .
ADVANCES IN THERAPY, 2021, 38 (08) :4480-4504
[37]   Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: interim analysis from a post-marketing surveillance study [J].
Kaku, Kohei ;
Chin, Rina ;
Naito, Yusuke ;
Iliev, Hristo ;
Ikeda, Rie ;
Ochiai, Kaori ;
Yasui, Atsutaka .
EXPERT OPINION ON DRUG SAFETY, 2020, 19 (02) :211-221
[38]   Safety and effectiveness of efgartigimod for intravenous infusion in patients with generalized myasthenia gravis: an interim analysis of Japanese post-marketing surveillance [J].
Teranishi, Hirofumi ;
Tsuda, Koichi ;
Kanzaki, Rumiko ;
Hayashi, Tomoyo ;
Harada, Daisuke .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2025, 25 (05) :543-550
[39]   Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance [J].
Kameda, Hideto ;
Tasaka, Sadatomo ;
Takahashi, Toshiya ;
Suzuki, Katsuhisa ;
Soeda, Naoki ;
Tanaka, Yoshiya .
MODERN RHEUMATOLOGY, 2024, 34 (03) :444-452
[40]   Impact of alectinib on survival after crizotinib failure in ALK-positive NSCLC patients. [J].
Yoshida, Tatsuya ;
Oya, Yuko ;
Shimizu, Junichi ;
Tanaka, Kosuke ;
Horio, Yoshitsugu ;
Hida, Toyoaki ;
Yatabe, Yasushi .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)